"Haloperidol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
Below are MeSH descriptors whose meaning is more general than "Haloperidol".
Below are MeSH descriptors whose meaning is more specific than "Haloperidol".
This graph shows the total number of publications written about "Haloperidol" by people in Harvard Catalyst Profiles by year, and whether "Haloperidol" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 5 | 3 | 8 |
| 1994 | 4 | 7 | 11 |
| 1995 | 5 | 4 | 9 |
| 1996 | 5 | 4 | 9 |
| 1997 | 4 | 7 | 11 |
| 1998 | 1 | 5 | 6 |
| 1999 | 4 | 5 | 9 |
| 2000 | 2 | 4 | 6 |
| 2001 | 3 | 5 | 8 |
| 2002 | 6 | 4 | 10 |
| 2003 | 5 | 4 | 9 |
| 2004 | 5 | 4 | 9 |
| 2005 | 5 | 10 | 15 |
| 2006 | 6 | 8 | 14 |
| 2007 | 6 | 3 | 9 |
| 2008 | 6 | 5 | 11 |
| 2009 | 1 | 4 | 5 |
| 2010 | 3 | 4 | 7 |
| 2011 | 2 | 3 | 5 |
| 2012 | 2 | 1 | 3 |
| 2013 | 4 | 1 | 5 |
| 2014 | 3 | 4 | 7 |
| 2015 | 2 | 1 | 3 |
| 2016 | 3 | 4 | 7 |
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 3 | 6 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 5 | 7 |
| 2021 | 2 | 1 | 3 |
| 2022 | 2 | 2 | 4 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Haloperidol" by people in Profiles.
-
Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization. JAMA Netw Open. 2023 02 01; 6(2):e230063.
-
Haloperidol for Treatment of ICU Delirium - Progress or Setback? N Engl J Med. 2022 12 29; 387(26):2464-2465.
-
Pharmacologic treatment of delirium symptoms: A systematic review. Gen Hosp Psychiatry. 2022 Nov-Dec; 79:60-75.
-
Intravenous Haloperidol Has a Limited Role in the Modern Emergency Department. Ann Emerg Med. 2023 01; 81(1):96-98.
-
Psychopharmacology of agitation in acute psychotic and manic episodes. Curr Opin Psychiatry. 2022 05 01; 35(3):171-176.
-
Association Between Incident Delirium Treatment With Haloperidol and Mortality in Critically Ill Adults. Crit Care Med. 2021 08 01; 49(8):1303-1311.
-
Who Should Implement Force When It's Needed and How Should It Be Done Compassionately? AMA J Ethics. 2021 04 01; 23(4):E311-317.
-
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis. Am J Psychiatry. 2021 05 01; 178(5):424-436.
-
A Retrospective Comparison of the Effectiveness and Safety of Intravenous Olanzapine Versus Intravenous Haloperidol for Agitation in Adult Intensive Care Unit Patients. J Intensive Care Med. 2022 Feb; 37(2):222-230.
-
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia. Psychiatry Res. 2021 01; 295:113641.